ESMO 2022: Highlights, commentary and analysis
ESMO 2022: Highlights, commentary and analysis
A new era of early cancer detection with blood test may change cancer screening paradigms
New era of early cancer detection blood tests on the horizon
Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19
Working to improve global cancer care access in low middle-income countries
Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes
War in Ukraine: Global cancer aid to support refugees
ASCO and WHO to collaborate on quality indicators for cancer facilities
Spotlight on global cancer control at ASCO 2022
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries
Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas
Information sharing experiences of professionals looking after children with cancer